MedPath

A Photodynamic Therapy for Treatment of Actinic Keratoses

Not Applicable
Completed
Conditions
Actinic Keratoses
Interventions
Procedure: Photodynamic therapy
Registration Number
NCT00558688
Lead Sponsor
Northwestern University
Brief Summary

The purpose of this study is to compare the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs absence of treatment for actinic keratoses.

Detailed Description

This study seeks to evaluate the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs. absence of treatment for actinic keratoses

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Age greater than or equal to 18 years

  • Have a t least 4 nonhypertrophic AK lesions on the body
  • The subjects are in good health
  • The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate to the investigator
Exclusion Criteria
  • Subjects who are pregnant or lactating
  • Subjects with a history of cutaneous photosensitivity or porphyria, hypersensitivity to porphyrins, or photodermatosis
  • Subjects with use of photosensitizing drugs within 1 week of study start
  • Subjects with use of topical medications such as corticosteroids, alpha-hydroxyacids or retinoids 2 weeks before study entry
  • Subjects with systemic steroid therapy within 4 weeks before study entry
  • Subjects who received previous treatment of target AKs
  • Subjects with systemic treatment with chemotherapeutic agents, masoprocol (Actinex), immunotherapy, or retinoids within 2 months of study entry
  • Subjects with prior history of hypersensitivity reactions to lidocaine
  • Subjects who are unable to understand the protocol or to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Photodynamic therapyLight Therapy
2Photodynamic therapyLight Therapy
Primary Outcome Measures
NameTimeMethod
Visual assessment of lesions4 weeks
Secondary Outcome Measures
NameTimeMethod
Patient subjective assessment and Safety4 weeks

Trial Locations

Locations (1)

Northwestern University Department of Dermatology

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath